Maghawry Hanan Faried, Darwish Alaa M, Mohammed Naglaa Abd Elmeged, El-Hameed Nadia Abd El-Ghany Abd, Ahmed Gellan K
Department of Psychiatric and Mental Health Nursing, Faculty of Nursing, Assiut University, Assiut, Egypt.
Department of Neurology and Psychiatry, Assiut University, Assiut, 71516, Egypt.
BMC Psychol. 2025 Apr 10;13(1):367. doi: 10.1186/s40359-025-02638-8.
Opioid use is a growing concern worldwide with high relapse rates and psychiatric comorbidities. Emotional intelligence (EI) has been associated with positive health outcomes, yet limited research exists on EI-based interventions for opioid use disorders. The study aimed to assess EI levels among individuals with opioid addiction and implement an EI program to reduce addiction severity and relapse rates, as well as examine potential factors that contribute to enhancing EI.
A quasi-experimental study assigned 40 males with opioid use disorder into an intervention group receiving a 2-week EI program (n = 20) and a control group (n = 20). Healthy comparison group (without opioid use disorder) (n = 20) was also included. Measures including the Emotional Intelligence Scale, Personality Inventory for DSM-5, Symptom Checklist-90-Revised (SCL-90-R), Addiction Severity Index, and Advance Warning of Relapse (AWARE) questionnaire were used to assess the groups at baseline,2 weeks and 3-month follow-up in patients with opioid use disorder.
The healthy group exhibited lower scores on disinhibited personality subscales, maladaptive personality traits, and SCL-90-R subscales than the opioid addiction groups at baseline. The EI intervention group displayed substantial increases in EI subscale scores at the second and third follow-up assessments compared to the control group. At AWARE scale follow-up, all control group patients had relapsed, versus only one patient in the EI intervention group.
Participants with opioid addiction demonstrated lower baseline EI and higher rates of psychiatric symptoms and maladaptive personality traits than healthy group. A brief EI intervention led to significant EI increases and lower relapse rate versus standard treatment alone.
阿片类药物的使用在全球范围内日益受到关注,其复发率高且常伴有精神疾病共病。情商(EI)与积极的健康结果相关,但针对阿片类药物使用障碍的基于情商的干预措施的研究却很有限。本研究旨在评估阿片类药物成瘾者的情商水平,并实施一项情商计划以降低成瘾严重程度和复发率,同时研究有助于提高情商的潜在因素。
一项准实验研究将40名患有阿片类药物使用障碍的男性分为干预组(n = 20)和对照组(n = 20),干预组接受为期2周的情商计划。还纳入了健康对照组(无阿片类药物使用障碍)(n = 20)。使用包括情商量表、《精神疾病诊断与统计手册》第5版人格量表、症状自评量表90修订版(SCL - 90 - R)、成瘾严重程度指数和复发预警(AWARE)问卷等测量工具,在基线、2周和3个月随访时对阿片类药物使用障碍患者的各组进行评估。
在基线时,健康组在冲动控制人格子量表、适应不良人格特质和SCL - 90 - R子量表上的得分低于阿片类药物成瘾组。与对照组相比,情商干预组在第二次和第三次随访评估时情商量表子量表得分大幅提高。在AWARE量表随访时,所有对照组患者均复发,而情商干预组仅有1例患者复发。
与健康组相比,阿片类药物成瘾参与者的基线情商较低,精神症状和适应不良人格特质的发生率较高。与单纯标准治疗相比,简短的情商干预导致情商显著提高且复发率降低。